Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
暂无分享,去创建一个
I. Hyodo | H. Kuwano | K. Muro | S. Morita | H. Baba | Masahiko Watanabe | K. Sugihara | T. Satoh | Y. Shimada | N. Boku | H. Takiuchi | T. Nishina | K. Yamaguchi | Y. Komatsu | T. Denda | A. Tsuji | S. Tokunaga | T. Esaki | S. Sameshima | K. Ina | M. Watanabe